INTRODUCTION
Childhood obesity is a major factor for the metabolic syndrome and cardiovascular diseases. Obesity in early childhood further increases the risk of premature illnesses and early death (1) . Baerdet-Biedl syndrome (BBS) is a genetic autosomal recessive disease characterized by obesity, mental retardation, postaxial polydactyly, retinitis pigmentosa, hypogonadism, and renal abnormalities (2) . Our two cases with BBS associated syndromic obesity were diagnosed as early metabolic syndrome. Since, a classic metabolic syndrome characterized by phrothrombotic risk and proinflamatory states and obese children associated with metabolic syndrome may be under the risk of thromboembolic disease, cardiovascular and thromboembolic diseases should be genetically investigated in obese children. In this study, cardiovascular and thromboembolic diseases were genetically investigated in two cases of BBS associated with obesity and metabolic syndrome.
PATIENTs and METHODs
Our two cases with BBS admitted to pediatric endocrinology department of our hospital for obesity. Both cases were evaluated in our department by a detailed physical examination, pubertal staging, and anthropometric evaluations (chronological age, height, weight, standing height (expressed as SD score), body mass index (BMI: weight (kg)/height (meters 2 ). The pubertal development stage was assessed by the same pediatric endocrinologist using criteria of Tanner classification. In the physical examination, acanthosis nigrigans reflexing insulin resistance was noticed in each case. Clinical and laboratory characteristics of both cases are shown in Tables I, II. The clinical diagnosis of metabolic syndrome was described as abnormal glucose homeostasis, impaired fasting glucose, fasting hyperinsulinemia, impaired glucose tolerance, hypertension, and dyslipidemia. Metabolic syndrome was defined as having more than 3 criterias. For homeostasis model assessment of insulin resistance (HOMA-IR) (fasting glucose (nmol/L) x fasting insulin (mıu/ml), a cut off value of 22.5 was used as index of insulin resistance (2, 3) . The criteria of metabolic syndrome were defined according to modified WHO criteria (3).
According to WHO criteria, metabolic syndrome was defined as follows; Obesity (BMI >95th percentile for age and sex) Abnormal glucose homeostasis (fasting glucose (≥100 mg/dl), fasting hyperinsulinemia (prepubertal >15 mU/L, pubertal >30 mU/L), impaired glucose tolerance (OGTT 120 min;200mg/ dl>plasma glucose level> or = 140mg/dl) bu kısım anlaşılmıyor Hypertension (systolic blood pressure >95th percentile for age and sex) Dyslipidemia (triglycerides <10 years, >102 mg/dl; >10 years, >136 mg/dl; low LDL-cholesterol, <135 mg/dl; high totalcholesterol >95th percentile)
Our cases had at least 3 criterias related to metabolic syndrome. Parameters of the cases relevant to metabolic syndrome are summarized in Table II. General appearances of the cases, their hands and feet operated for polydactyly are demonstrated in Figures 1, 2 . Maculopathy observed in case 1 and retinitis pigmentosa in both cases are illustrated in Figure 3 . In both cases, Table I : Clinical characteristics of our cases with BBS. (Table III) .
Informed consent was taken from all subjects.
DIsCUssION
Coronary artery disease and atherosclerosis can be seen at any age in the population and have a high mortality. Childhood obesity is a major risk factor especially for the metabolic syndrome and further cardiovascular diseases. About one third of obese children and adolescents exhibit features of early metabolic syndrome (5) . Therefore, determining genetic risk factors is important in establishing treatment strategies of obesity at early ages. About 2-3% of "essential" obesity in pediatric age has endocrine or genetic origin. A smaller proportion of such cases accounts for some rare syndromes. Obesity, hypertension, diabetes mellitus, hyperhomocystinemia, and constitutional abnormalities observed in syndromic cases may cause early development of vascular diseases. One of these syndromes is Bardet-Biedl syndrome that has an autosomal recessive inheritence and multi-system involvement. Eight different loci have been identified on 2q31 (BBS5), 3p13 (BBS3), 4q27 (BBS7), 11q13 (BBS1), 13q32 (BBS8), 15q22.3 (BBS4), 16q21 (BBS2) and 20p12 (BBS6) (6) for BBs. BBS leads to multiple handicaps (visual impairment, complication of obesity, renal failure, and endocrine dysfunction) (7). Recent discoveries have lead to the hypothesis that ciliary dysfunction is a mechanism underlying the pathogenesis of BBS (8, 9) . In this syndrome, all these clinical features can be seen in only 40-45% of the cases. One study reported that children with BBS show clinical features of obesity in 90-95%, mental retardation in 80-87%, polydactyly in 70-74%, and hypogonadism in 65-99% of cases (9) . Obesity is one of the primary clinical features of BBS. The causes of obesity resulted from both pituitary and hypothalamic abnormalities (10, 11) . Obesity usually begins in childhood and severity of obesity increases with age (12) . Among the most common sequelae of childhood obesity are hypertension and dyslipidemia. We determined obesity and dyslipidemia in both of our cases. In such cases, a careful cardiovascular evaluation should be performed.
Impaired oral glucose tolerance test (OGTT) and diabetes mellitus are present in 32% of children with BBS. OGTT was performed for our cases and it revealed impaired glucose tolerance. We determined insulin resistance in case 1 and impaired glucose tolerance in case 2 (Table I) . BBS and metabolic syndrome association is a common situation. On cases with metabolic syndrome, investigation of 12 cardiovascular disease (CVD) alleles (factor V, factor XIII, PAI-1, HPA-1, MTHRR C677T, Apo-B, Apo-E) could be usefull by reverse hybridization method. To investigate susceptibility to cardiovascular diseases of our cases diagnosed as BBS syndrome, polymorphisms of 12 CVD risk alleles were searched in their the other hand, in literature, there were insufficient researches about BBS and metabolic syndrome association.
The ocular manifestations of BBS include an early and severe rod-cone dystrophia causing legal blindness in the second decade. Other ophthalmologic signs include nistagmus, myopia, optic atrophy, macular dystrophy, strabismus, and cataracts. Our cases had retinitis pigmentosa and macular dystrophy consistent with other reported articles.
In their autopsy study; McLoughlin and Shanklin reported that 69% of cases with BBS had cardiovascular disorder (13) . Congenital cardiac abnormalities include atrial and ventricular septal defects and patent ductus arteriosus. We detected no cardiovascular abnormalities in transthoracic echocardiograms of our cases.
In cases with BBS, risk of cardiovascular disease is high because of damaged vascular structure, metabolic syndrome, prothrombotic, and proinflammatory states. Our two cases with BBS associated with syndromic obesity were diagnosed as metabolic syndrome. Classical metabolic syndrome is characterized by prothrombotic risk and proinflamatory states. In order to determine susceptibility to cardiovascular diseases in sera by reverse hybridization method (14) . Methylenetetrahydrofolate reductase C677T (MTHFR C677T) variation leads to increase of plasma homocysteine concentration in individuals with low folic acid concentration. It was demonstrated that high homocysteine levels may increase the risk of thromboembolism and atherosclerosis (15) . Heterozygous and homozygous mutations of MTHFR C677T were detected in our cases (Table III) .
Deletion of guanosine in -675 (4G-allele) position in the promoter site of plasminogen activator inhibitor (PAI) gene leads to an increase in blood concentration of PAI-1.
Heterozygous 4G-allele is associated with an increase in myocardial infarction risk. In the patients carriers of heterozygous 4G allele, the risk of vascular occlusion further increases if the patients are also carriers of Factor V Leiden mutation (13) .
Syndromic and nonsyndromic obesity is a metabolic disorder that is associated with increased plasminogen activator inhibitor-1 (PAI-1) concentration in the circulation. This increase is related to insulin resistance, dyslipidemia, and cardiovascular disease. Also some studies have demonstrated a relationship between plasma PAI-1 concentrations and 4G/5G gene polymorphism on the PAI-1 gene while other studies have not (1) . On the other hand, atherothrombotic complications in patients with insulin resistance and obesity are partly attributed to impaired fibrinolysis caused by increase in plasma levels of PAI-1 and 4G/5G promoter polymorphism of the PAI-1 gene (13) . In both of our cases, 4G/5G heterozygous polymorphism was detected (Table III) . In a study of performed in 2006, 134 nonsyndromic obese Turkish children were evaluated and the frequency of 4G/4G genotype was more than 4G/5G and 5G/5G genotypes on the PAI-1 gene (1). The patients with 4G/5G promoter polymorphism of the PAI-1 gene can be at increased risk for devoloping vascular disease.
In people carrying Apo-E3/3 mutation, serum LDL-cholesterol level was high. Homozygous mutation is seen rarely in Apo. Heterozygous mutation also causes an increase in serum LDLcholesterol level (7) . In our cases, Apo-E3/3 mutation and high serum LDL-cholesterol level were found.
Glycoprotein III a is a fibrinogen receptor on the platelet membrane. Allele-a is defined as normal allele. Allele-b increases susceptibility to acute coronary events and myocardial infarction at early ages. Polymorphism in glycoprotein III a receptor (HPA-1) gene was also found in both cases.
In conclusion, childhood obesity is a major risk factor, especially for metabolic syndrome and further cardiovascular diseases. In syndromic cases of obesity such as Bardet-Biedl Syndrome, possibility of thromboembolic events at early ages should be kept in mind and necessary preventive measures should be taken. Genetic susceptibility for CVD is detected in syndromic cases with obesity, monitoring these patients may be life saving especially during the conditions of severe infection, dehydration, and operation.
